Cost-effectiveness of IGRA/QFT-Plus for TB screening of migrants in Oman
Copyright © 2020. Published by Elsevier Ltd..
OBJECTIVE: To estimate the cost of a screening program for identifying latent tuberculosis (TB) infections in migrants to Oman.
METHODS: A Markov model was used to estimate the cost of screening using an interferon-gamma release assay (IGRA) applied to all migrants from high TB endemic countries, followed by preventive TB treatment.
RESULTS: The model compared seven different scenarios, with a comparison of the direct cost and the quality-adjusted life-years (QALYs) saved.
CONCLUSIONS: IGRA testing followed by 3 months of preventive treatment with rifapentine/isoniazid (3HP) was the most cost-effective intervention.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:92S |
---|---|
Enthalten in: |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 92S(2020) vom: 01. März, Seite S72-S77 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Al Abri, Seif [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cost |
---|
Anmerkungen: |
Date Completed 10.06.2020 Date Revised 10.06.2020 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ijid.2020.03.010 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM307599450 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM307599450 | ||
003 | DE-627 | ||
005 | 20231225125921.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijid.2020.03.010 |2 doi | |
028 | 5 | 2 | |a pubmed24n1025.xml |
035 | |a (DE-627)NLM307599450 | ||
035 | |a (NLM)32171953 | ||
035 | |a (PII)S1201-9712(20)30129-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Al Abri, Seif |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cost-effectiveness of IGRA/QFT-Plus for TB screening of migrants in Oman |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.06.2020 | ||
500 | |a Date Revised 10.06.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020. Published by Elsevier Ltd. | ||
520 | |a OBJECTIVE: To estimate the cost of a screening program for identifying latent tuberculosis (TB) infections in migrants to Oman | ||
520 | |a METHODS: A Markov model was used to estimate the cost of screening using an interferon-gamma release assay (IGRA) applied to all migrants from high TB endemic countries, followed by preventive TB treatment | ||
520 | |a RESULTS: The model compared seven different scenarios, with a comparison of the direct cost and the quality-adjusted life-years (QALYs) saved | ||
520 | |a CONCLUSIONS: IGRA testing followed by 3 months of preventive treatment with rifapentine/isoniazid (3HP) was the most cost-effective intervention | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cost | |
650 | 4 | |a DAILYs | |
650 | 4 | |a Latent tuberculosis | |
650 | 4 | |a Screening | |
650 | 7 | |a Isoniazid |2 NLM | |
650 | 7 | |a V83O1VOZ8L |2 NLM | |
650 | 7 | |a Rifampin |2 NLM | |
650 | 7 | |a VJT6J7R4TR |2 NLM | |
650 | 7 | |a rifapentine |2 NLM | |
650 | 7 | |a XJM390A33U |2 NLM | |
700 | 1 | |a Kowada, Akiko |e verfasserin |4 aut | |
700 | 1 | |a Yaqoubi, Fatma |e verfasserin |4 aut | |
700 | 1 | |a Al Khalili, Sulien |e verfasserin |4 aut | |
700 | 1 | |a Ndunda, Nduku |e verfasserin |4 aut | |
700 | 1 | |a Petersen, Eskild |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases |d 1998 |g 92S(2020) vom: 01. März, Seite S72-S77 |w (DE-627)NLM094730857 |x 1878-3511 |7 nnns |
773 | 1 | 8 | |g volume:92S |g year:2020 |g day:01 |g month:03 |g pages:S72-S77 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijid.2020.03.010 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 92S |j 2020 |b 01 |c 03 |h S72-S77 |